The Han Lab In the News
– MedPageLDCT Screening Linked to Lower Risk of Brain Mets in Lung Cancer
Patients with primary lung cancer detected with low-dose computed tomography (LDCT) screening have a lower risk of developing brain metastases than patients whose cancer was detected through other methods, researchers found.
– Docwire NewsPatients with Primary Lung Cancers Detected by LDCT at Reduced Risk of Brain Metasases - Docwire News
A new study shows that patients with primary lung cancer detected using low-dose computed tomography (LDCT) screening have a lower risk of the cancer spreading to the brain, of developing brain metastases after diagnosis, according to a study published in the Journal of Thoracic Oncology.
– News Medical Life SciencesLung cancer detected by LDCT screening linked to lower brain metastases risk
Patients with primary lung cancer detected using low-dose computed tomography screening are at reduced risk of developing brain metastases after diagnosis, according to a study published in the Journal of Thoracic Oncology.
– Diagnostic ImagingLung Cancer Detection with LDCT Linked to Lower Brain Metastasis Risk
Patients who have their disease detected with low-dose CT have a half-fold risk of brain metastasis than patients screened with other methods. Add a lower risk of brain metastasis to the ever-growing list of benefits associated with low-dose CT (LDCT) lung cancer screening. According to a study published June 3 in the Journal of Thoracic Oncology, patients who have their lung cancer detected with LDCT have half the risk of a subsequent brain metastasis than do patients whose disease is diagnosed via alternative methods.